Advertisement

Topics

Reveal Biosciences, LLC Company Profile

16:23 EDT 25th April 2018 | BioPortfolio

Reveal Biosciences is a leading contract research organization that specializes in advanced tissue technology services and tissue-based research. Their portfolio of services includes histology, immunohistochemistry (IHC), immunofluorescence (IF), proprietary multiplex technology, whole slide imaging, and image analysis/quantification, as well as novel RNA ISH technologies, such as RNAscope. Reveal Biosciences is also applying their expertise in advanced tissue technologies to develop innovative diagnostics and companion diagnostics. Learn more about Reveal Biosciences’ full range of advanced tissue technology services at http://www.revealbiosciences.com.


News Articles [933 Associated News Articles listed on BioPortfolio]

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

Kuros Biosciences Ltd.: Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus

Schlieren (Zürich), Schweiz, 8. Januar 2018 Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus Kuros Biosciences AG (SIX: KURN) gibt die Ausdehnung des exklusiven Lizenzabkommens mit Checkm...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Apricus Biosciences, Inc.: Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative me...

Kuros Biosciences Ltd.: Kuros Biosciences sichert mögliche Eigenkapitalfinanzierung von bis zu CHF 30 Millionen

Schlieren (Zürich), Schweiz, 22. November 2017 Kuros Biosciences sichert mögliche Eigenkapitalfinanzierung von bis zu CHF 30 Millionen Kuros Biosciences (SIX: KURN) gibt den Abschluss eines Standb.....

Kuros Biosciences Ltd.: Kuros Biosciences gibt Nachfolge im Management bekannt

Schlieren (Zürich), Schweiz, 14. Dezember 2017 Kuros Biosciences gibt Nachfolge im Management bekannt Kuros Biosciences AG (SIX: KURN) gibt die Ernennung von Michael Grau zum Chief Financial Offic...

AB Biosciences & Shire Enter License Agreement

For AB Biosciences' pan receptor interacting molecule (PRIM) program

PubMed Articles [172 Associated PubMed Articles listed on BioPortfolio]

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Introduction.

Contents list.

Back cover.

Front cover.

Clinical Trials [248 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

To determine the efficacy of an improved rapid diagnostic test using venous whole blood and fingerstick whole blood. The clinical performance of Reveal G4 Rapid HIV-1 Antibody Test will be...

Reveal LINQ™ Heart Failure

The purpose of the LINQ™ HF study is to characterize Reveal LINQ™ derived data from patients with heart failure by assessing the relationship between changes in LINQ™ derived data and ...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Reveal® XT Performance Trial (XPECT)

The purpose of this study is to quantify the accuracy of the atrial fibrillation diagnostics of the Reveal® XT in a clinical setting and to verify overall system performance, R-wave sensi...

Medtronic Reveal LINQ Insertable Cardiac Monitor Registry

The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.

Companies [370 Associated Companies listed on BioPortfolio]

Reveal Biosciences, LLC

Reveal Biosciences is a leading contract research organization that specializes in advanced tissue technology services and tissue-based research. Their portfolio of services inclu...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Reveal

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Reveal Biosciences, LLC" on BioPortfolio

We have published hundreds of Reveal Biosciences, LLC news stories on BioPortfolio along with dozens of Reveal Biosciences, LLC Clinical Trials and PubMed Articles about Reveal Biosciences, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reveal Biosciences, LLC Companies in our database. You can also find out about relevant Reveal Biosciences, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...


Corporate Database Quicklinks



Searches Linking to this Company Record